Martorell, Fernando
June 1958
Angiology;Jun1958, Vol. 9 Issue 3, p191
Academic Journal
This article focuses on the treatment of intermittent claudication with "MY 301." "MY 301" is composed of glycine-ethyl-guaiacal, Levulose and water. It is prepared in ampules and may be administered either by intramuscular or intravenous injection. It comes in two strengths: 5 and 20 per cent glycine-ether, the latter being known as "strong." In order to understand the mechanism by which "MY 301" functions it is necessary to bear in mind that one of the recognized treatments or intermittent claudication and the most radical is tenotomy of the Achilles.


Related Articles

  • Treatment of intermittent claudication. Karthikeyan, G.; Eikelboom, John W. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/21/2009, p671 

    The authors reflect on methods which are used to treat intermittent claudication. They suggest that any methods that are used should improve the patient's symptoms and decrease the risk of cardiovascular problems. They argue that the most important goal of medical treatment in patients with...

  • Mortality and Morbidity in Patients with Intermittent Claudication in Relation to the Location of the Occlusive Atherosclerosis in the Leg. Tommy Jonason; Ivar Ringqvist // Angiology;May1985, Vol. 36 Issue 5, p310 

    Mortality and morbidity from cerebrovascular and coronary arterial disease over a period of six years were studied in 224 non-diabetic patients with intermittent claudication. Patients with multiple arterial stenoses in the leg had a lower six-year survival than patients with single stenoses...

  • Effects of Pentoxifylline on Severe Intermittent Claudication. Reich, Theobald; Gilings, Dennis // Angiology;Sep1987, Vol. 38 Issue 9, p651 

    Pentoxifylline has been shown to improve treadmill walking distances under blinded, controlled conditions in patients with intermittent claudication. From the pooled data of a blinded, controlled, randomized, multicenter trial, the data from all enrolled patients with severe claudication (< 70 m...

  • THE NATURAL COURSE OF ARTERIOSCLEROSIS OF THE LOWER EXTREMITIES. Boyd, A. M. // Angiology;Feb1960 Part 1, Vol. 11 Issue 1, p10 

    The article focuses on the arteriosclerosis of the lower extremities. The management of arteriosclerosis of the lower extremities has undergone a radical change during the last 10 years. The article collects a series of patients suffering from intermittent claudication due to arterisclerosis but...

  • ENTRAPMENT OF THE POPLITEAL ARTERY AND ITS MANAGEMENT. Husni, E. A.; Ryu, C. K. // Angiology;Jul/Aug1971, Vol. 22 Issue 7, p380 

    Examines the relationship between the popliteal artery and medial head of the gastroenemius muscle. Methods of popliteal artery management; Presentation of a case of a patient with popliteal artery entrapment syndrome; Alternative logical surgical approach for the treatment of the disease.

  • ELECTRONEUROGRAPHY IN INTERMITTENT CLAUDICATION DUE TO OBLITERATIVE ARTERIOSCLEROSIS. Kumlin, T.; Sepp�l�inen, A. M.; Railo, J. // Angiology;Jun1974, Vol. 25 Issue 6, p373 

    Studies on electromyographic changes in the lower limbs have been published in connection with obliterative arterial changes, because the blood supply of the sciatic nerve and its branches has its origin in the common iliac artery. Previous studies have dealt with maximal motor conduction and no...

  • Comparison of Safety and Efficacy of Buflomedil and Naftidrofuryl in the Treatment of Intermittent Claudication. Rosas, Guillermo; Cerdeyra, Cristina; Lucas, Miguel A.; Parano, Jorge R.; Villa, Juan J. // Angiology;May1981, Vol. 32 Issue 5, p291 

    In a group of 58 patients with peripheral arteriopathies, we have studied efficacy and safety of buflomedil hydrochloride and naftidrofuryl. Both drugs have been shown to have vasoactive properties evaluated through walking capacity and time of hyperemia. According to our results, buflomedil is...

  • PGE1 and Other Prostaglandins in the Treatment of Intermittent Claudication: A Meta-analysis. Amendt, Klaus // Angiology;Jul/Aug2005, Vol. 56 Issue 4, p409 

    In intermittent claudication, pharmacologic drugs and invasive measures are indicated in patients who do not benefit from exercise training. To evaluate the therapeutic role of prostaglandins (PGs), especially of prostaglandin E1 (PGE1), for this indication, the author performed a meta-analysis...

  • Levo-Propionyl-Carnitine Improves the Effectiveness of Supervised Physical Training on the Absolute Claudication Distance in Patients With Intermittent Claudication. Andreozzi, Giuseppe Maria; Leone, Alfredo; Laudani, Rita; Martini, Romeo; Deinite, Gregorio; Cataldi, Valentina // Angiology;Feb/Mar2008, Vol. 59 Issue 1, p84 

    The mechanisms by which supervised physical training improves walking ability in patients with intermittent claudication (IC) are microcircuIatory rheological, and metabolic. The main mechanism of levo-propionyl-carnitine (LPC) is metabolic; it increases the walking ability in claudicants,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics